Durosini Ilaria, Mazzocco Ketti, Triberti Stefano, Russo Gaetano Alessandro, Pravettoni Gabriella
Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Front Psychol. 2021 May 5;12:546636. doi: 10.3389/fpsyg.2021.546636. eCollection 2021.
Thanks to the evolution in medical and pharmaceutical research, to date, the number of cancer treatments is increasingly on the rise. Despite this, several side effects related to cancer treatments can exacerbate patients' physical and psychological conditions, such as cardiotoxicity. Over the years, researchers have explored the possible relationship between psychological variables and physical diseases. Even though some authors examined the relationship between personality and specific diseases, no scientific attention has been paid to the role of personality in the development of cardiotoxicity arising from cancer treatments. Yet this is an important objective, given that determining whether personality influences cardiac toxicity of anticancer treatments could inform the processes by which stable psychological factors influence health. This contribution summarizes and analyzes the available scientific evidence about the association between personality and main cardiotoxicity-related-diseases of anticancer therapies, including cancer and cardiovascular diseases, in order to sketch a hypothetical model of the relationship between personality traits and cardiotoxicity.
得益于医学和制药研究的发展,迄今为止,癌症治疗方法的数量日益增加。尽管如此,与癌症治疗相关的一些副作用会加剧患者的身体和心理状况,比如心脏毒性。多年来,研究人员探索了心理变量与身体疾病之间的可能关系。尽管一些作者研究了人格与特定疾病之间的关系,但尚未有人科学地关注人格在癌症治疗引起的心脏毒性发展中的作用。然而,这是一个重要目标,因为确定人格是否会影响抗癌治疗的心脏毒性可以为稳定的心理因素影响健康的过程提供信息。本论文综述并分析了关于人格与抗癌疗法主要心脏毒性相关疾病(包括癌症和心血管疾病)之间关联的现有科学证据,以勾勒出人格特质与心脏毒性之间关系的假设模型。